+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Prophylactic Antiobiotics Market - Global Forecast 2025-2030- Product Image
Prophylactic Antiobiotics Market - Global Forecast 2025-2030- Product Image
Sale

Prophylactic Antiobiotics Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6090470
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The prophylactic antibiotics market is evolving swiftly as antimicrobial stewardship, digital health innovation, and regional supply dynamics converge to reshape protocols and cost structures in healthcare delivery. Senior decision-makers must stay ahead of these changes to ensure effective risk mitigation and sustained patient outcomes.

Prophylactic Antibiotics Market Snapshot

The global prophylactic antibiotics market grew from USD 10.72 billion in 2024 to USD 11.13 billion in 2025. It is projected to expand at a 4.06% CAGR, reaching USD 13.61 billion by 2030. Market momentum is powered by strong hospital demand, increased surgical procedure volumes, and renewed approaches to infection prevention. Manufacturers, providers, and payers are recalibrating their strategies as stewardship initiatives and technological advancements set new standards in patient care. As institutional buyers intensify focus on safety and operational cost-control, the market is witnessing robust shifts in clinical guidelines, procurement, and distribution channels.

Scope & Segmentation

  • Type: Cephalosporins, flucloxacillin, gentamicin, tinidazole, vancomycin
  • Dosage Form: Intravenous, oral, topical
  • Application: Dental procedures, gynecological surgery, orthopedic surgery
  • End-User: Ambulatory surgical centers, homecare, hospitals and clinics
  • Distribution Channel: Hospital pharmacy, retail pharmacy
  • Regions Covered: Americas (including United States by major states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (with Western Europe and emerging markets), Asia-Pacific (China, India, Japan, Australia, South Korea, and others)
  • Key Companies Profiled: Amgen Inc., Biosynth Ltd, GlaxoSmithKline PLC, LEXICARE PHARMA PVT. LTD., Lupin Limited, Merck & Co., Inc., Novartis AG, Novo Nordisk A/S, Pfizer Inc., Roche Holding AG

Key Takeaways: Strategic Insights for Senior Leaders

  • Antimicrobial stewardship frameworks are reshaping clinical practice, driving precision in regimen selection and duration to combat resistance and optimize patient safety.
  • Digital innovations—such as remote monitoring platforms and predictive analytics—are improving adherence, facilitating data-driven decision-making, and expanding prophylactic reach to rural and outpatient settings.
  • Stringent regulatory changes are prompting the industry to prioritize advanced formulations and collaborative development, supporting a shift toward next-generation molecules and safer delivery systems.
  • Segmentation analysis reveals growing demand for tailored antibiotic protocols in dental, gynecological, and orthopedic procedures, each requiring distinct agent profiles and administration methods.
  • Hospital pharmacies remain central in managing inpatient needs, while retail channels are increasingly critical for outpatient access and inventory flexibility.
  • Regional strategies must navigate market complexity, from mature stewardship environments and robust supply chains in North America to infrastructure variability and expanding surgical capacities across Asia Pacific and EMEA.

Tariff Impact: Shaping Cost and Supply Strategy

Recent United States tariff measures are generating cost pressures throughout the supply chain, increasing prices for active pharmaceutical ingredients and finished formulations. This has prompted manufacturers to diversify sourcing strategies and consider regional partnerships for more resilient procurement. Healthcare facilities and distributors are actively revising inventory and engaging in strategic stockpiling to limit potential shortages. Industry players are also monitoring early movements in local manufacturing, which may offer long-term insulation from trade volatility and help maintain quality compliance in a shifting regulatory landscape.

Methodology & Data Sources

The analysis draws on a blend of peer-reviewed literature, regulatory guidelines, and industry publications, complemented by interviews with infectious disease experts and procurement leaders. Data triangulation, secondary sources, and expert panel reviews ensure the integrity and depth of all findings on the prophylactic antibiotics market.

Why This Report Matters

  • Enables informed decisions on antimicrobial stewardship, supply chain risk management, and technology investments.
  • Delivers actionable market segmentation and regional intelligence to support differentiated growth strategies.
  • Guides senior executives in anticipating regulatory shifts and aligning clinical practice with operational priorities.

Conclusion

With changing clinical, regulatory, and supply dynamics, this report equips leaders to drive sustainable growth and uphold patient safety in the evolving prophylactic antibiotics landscape. Align your strategies with market reality to maintain a competitive edge.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of antibiotic-coated orthopedic implants to prevent postoperative infections
5.2. Increased utilization of single-dose prophylactic antibiotics in ambulatory surgical centers
5.3. Expansion of prophylactic antibiotic use in veterinary surgery to tackle zoonotic disease risks
5.4. Development of narrow-spectrum antibiotics aimed at reducing gut microbiome disruption during surgery
5.5. Growing demand for oral antibiotic regimens in dental prophylaxis for patients with heart conditions
5.6. Impact of antimicrobial stewardship programs on prophylactic antibiotic prescription patterns in hospitals
5.7. Regulatory tightening around antibiotic prophylaxis duration to combat antimicrobial resistance
5.8. Integration of rapid pathogen detection diagnostics to guide targeted prophylactic antibiotic therapy
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Prophylactic Antiobiotics Market, by Type
8.1. Introduction
8.2. Cephalosporins
8.3. Flucloxacillin
8.4. Gentamicin
8.5. Tinidazole
8.6. Vancomycin
9. Prophylactic Antiobiotics Market, by Dosage Form
9.1. Introduction
9.2. Intravenous
9.3. Oral
9.4. Topical
10. Prophylactic Antiobiotics Market, by Application
10.1. Introduction
10.2. Dental Procedures
10.3. Gynecological surgery
10.4. Orthopedic Surgery
11. Prophylactic Antiobiotics Market, by End-User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Homecare
11.4. Hospitals & Clinics
12. Prophylactic Antiobiotics Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.3. Retail Pharmacy
13. Americas Prophylactic Antiobiotics Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Prophylactic Antiobiotics Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Prophylactic Antiobiotics Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Amgen Inc.
16.3.2. Biosynth Ltd
16.3.3. GlaxoSmithKline PLC
16.3.4. LEXICARE PHARMA PVT. LTD.
16.3.5. Lupin Limited
16.3.6. Merck & Co., Inc.
16.3.7. Novartis AG
16.3.8. Novo Nordisk A/S
16.3.9. Pfizer Inc.
16.3.10. Roche Holding AG
17. Research AI18. Research Statistics19. Research Contacts20. Research Articles21. Appendix
List of Figures
FIGURE 1. PROPHYLACTIC ANTIOBIOTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. PROPHYLACTIC ANTIOBIOTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. PROPHYLACTIC ANTIOBIOTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. PROPHYLACTIC ANTIOBIOTICS MARKET: RESEARCHAI
FIGURE 26. PROPHYLACTIC ANTIOBIOTICS MARKET: RESEARCHSTATISTICS
FIGURE 27. PROPHYLACTIC ANTIOBIOTICS MARKET: RESEARCHCONTACTS
FIGURE 28. PROPHYLACTIC ANTIOBIOTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PROPHYLACTIC ANTIOBIOTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY CEPHALOSPORINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY CEPHALOSPORINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY FLUCLOXACILLIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY FLUCLOXACILLIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY GENTAMICIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY GENTAMICIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TINIDAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TINIDAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY VANCOMYCIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY VANCOMYCIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DENTAL PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DENTAL PROCEDURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY HOMECARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 75. CANADA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 76. CANADA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 77. CANADA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 78. CANADA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 79. CANADA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 80. CANADA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 81. CANADA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 82. CANADA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 83. CANADA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 84. CANADA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 85. MEXICO PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 86. MEXICO PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 87. MEXICO PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 88. MEXICO PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 89. MEXICO PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 90. MEXICO PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 91. MEXICO PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 92. MEXICO PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 93. MEXICO PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 94. MEXICO PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 95. BRAZIL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 96. BRAZIL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 97. BRAZIL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 98. BRAZIL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 99. BRAZIL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 100. BRAZIL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 101. BRAZIL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 102. BRAZIL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 103. BRAZIL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 104. BRAZIL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 105. ARGENTINA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 106. ARGENTINA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 107. ARGENTINA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 108. ARGENTINA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 109. ARGENTINA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. ARGENTINA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. ARGENTINA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 112. ARGENTINA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 113. ARGENTINA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. ARGENTINA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 128. UNITED KINGDOM PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 130. UNITED KINGDOM PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 132. UNITED KINGDOM PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 134. UNITED KINGDOM PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. UNITED KINGDOM PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. GERMANY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 138. GERMANY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 139. GERMANY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 140. GERMANY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 141. GERMANY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 142. GERMANY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 143. GERMANY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 144. GERMANY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 145. GERMANY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. GERMANY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. FRANCE PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 148. FRANCE PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 149. FRANCE PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 150. FRANCE PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 151. FRANCE PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 152. FRANCE PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 153. FRANCE PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 154. FRANCE PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 155. FRANCE PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 156. FRANCE PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 157. RUSSIA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 158. RUSSIA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 159. RUSSIA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 160. RUSSIA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 161. RUSSIA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 162. RUSSIA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 163. RUSSIA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 164. RUSSIA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 165. RUSSIA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. RUSSIA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. ITALY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 168. ITALY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 169. ITALY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 170. ITALY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 171. ITALY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 172. ITALY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 173. ITALY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 174. ITALY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 175. ITALY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. ITALY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. SPAIN PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 178. SPAIN PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 179. SPAIN PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 180. SPAIN PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 181. SPAIN PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 182. SPAIN PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 183. SPAIN PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 184. SPAIN PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 185. SPAIN PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. SPAIN PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 198. SAUDI ARABIA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 200. SAUDI ARABIA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 202. SAUDI ARABIA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 204. SAUDI ARABIA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. SAUDI ARABIA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 208. SOUTH AFRICA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 210. SOUTH AFRICA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. SOUTH AFRICA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. SOUTH AFRICA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 214. SOUTH AFRICA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 215. SOUTH AFRICA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. SOUTH AFRICA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. DENMARK PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 218. DENMARK PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 219. DENMARK PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 220. DENMARK PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 221. DENMARK PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. DENMARK PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. DENMARK PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 224. DENMARK PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 225. DENMARK PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. DENMARK PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. NETHERLANDS PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 228. NETHERLANDS PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 229. NETHERLANDS PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 230. NETHERLANDS PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 231. NETHERLANDS PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. NETHERLANDS PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. NETHERLANDS PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 234. NETHERLANDS PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 235. NETHERLANDS PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. NETHERLANDS PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. QATAR PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 238. QATAR PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 239. QATAR PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 240. QATAR PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 241. QATAR PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 242. QATAR PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 243. QATAR PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 244. QATAR PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 245. QATAR PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. QATAR PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. FINLAND PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 248. FINLAND PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 249. FINLAND PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 250. FINLAND PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 251. FINLAND PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. FINLAND PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. FINLAND PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 254. FINLAND PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 255. FINLAND PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. FINLAND PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. SWEDEN PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 258. SWEDEN PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 259. SWEDEN PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 260. SWEDEN PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 261. SWEDEN PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. SWEDEN PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. SWEDEN PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 264. SWEDEN PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 265. SWEDEN PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 266. SWEDEN PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 267. NIGERIA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 268. NIGERIA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 269. NIGERIA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 270. NIGERIA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 271. NIGERIA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 272. NIGERIA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 273. NIGERIA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 274. NIGERIA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 275. NIGERIA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. NIGERIA PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. EGYPT PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 278. EGYPT PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 279. EGYPT PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 280. EGYPT PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 281. EGYPT PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 282. EGYPT PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 283. EGYPT PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 284. EGYPT PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 285. EGYPT PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. EGYPT PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. TURKEY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 288. TURKEY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 289. TURKEY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 290. TURKEY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 291. TURKEY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 292. TURKEY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 293. TURKEY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 294. TURKEY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 295. TURKEY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. TURKEY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. ISRAEL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 298. ISRAEL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 299. ISRAEL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 300. ISRAEL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 301. ISRAEL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 302. ISRAEL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 303. ISRAEL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 304. ISRAEL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 305. ISRAEL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 306. ISRAEL PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 307. NORWAY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 308. NORWAY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 309. NORWAY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 310. NORWAY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 311. NORWAY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 312. NORWAY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 313. NORWAY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 314. NORWAY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 315. NORWAY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 316. NORWAY PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 317. POLAND PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 318. POLAND PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 319. POLAND PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 320. POLAND PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 321. POLAND PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 322. POLAND PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 323. POLAND PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 324. POLAND PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 325. POLAND PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 326. POLAND PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 327. SWITZERLAND PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 328. SWITZERLAND PROPHYLACTIC ANTIOBIOTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 329. SWITZERLAND PROPH

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Prophylactic Antiobiotics market report include:
  • Amgen Inc.
  • Biosynth Ltd
  • GlaxoSmithKline PLC
  • LEXICARE PHARMA PVT. LTD.
  • Lupin Limited
  • Merck & Co., Inc.
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Roche Holding AG

Table Information

Report AttributeDetails
No. of Pages189
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 11.13 billion
Forecasted Market Value ( USD ) by 2030 $ 13.61 billion
Compound Annual Growth Rate4.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Corifact Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts - Product Image

Corifact Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • Report
  • 175 Pages
  • Global
From
Roctavian Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts - Product Image

Roctavian Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • Report
  • 175 Pages
  • Global
From
Air Pressure Therapy - Global Strategic Business Report - Product Image

Air Pressure Therapy - Global Strategic Business Report

  • Report
  • 476 Pages
  • Global
From
Flea and Tick Control Medication - Global Strategic Business Report - Product Image

Flea and Tick Control Medication - Global Strategic Business Report

  • Report
  • 477 Pages
  • Global
From
Pharma Grade Potassium Chloride Market - Global Forecast 2025-2030 - Product Image

Pharma Grade Potassium Chloride Market - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.